2026年6月最新影响因子数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
体验更多LetPub AI科研工具 >> | |
| 近期推荐： | 热 Wiley 2026暑期线上学习营 | 报名正式开启！ | 热 多本ABS四星！优质经管国际期刊列表 | 热 全流程投稿协助套餐服务 |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Clinical Pharmacology in Drug Development CLIN PHARM DRUG DEV （此期刊被最新的JCR期刊SCIE收录） LetPub评分 5.4
52人评分
我要评分
声誉 6.4 影响力 3.8 速度 9.1 | |||||||||||||||||||||
| 期刊ISSN | 2160-7648 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||
| P-ISSN | 2160-763X | |||||||||||||||||||||
| 2025-2026最新IF （数据来源于网友提供） | 注册或登录后，查看IF | |||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日：1.64 | |||||||||||||||||||||
| 2025-2026自引率 | 5.9%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年IF （数据来源于网友提供） | 1.898数据由网友[淡然坦然]收集提供 | |||||||||||||||||||||
| h-index | 16 | |||||||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2160-7648 | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
| 期刊投稿网址 | http://mc.manuscriptcentral.com/cpd | |||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Effect of High-Fat Meal on the Pharmacokinetics and Safety of Lansoprazole Enteric-Coated Capsules in Healthy Chinese Subjects Author: Wang, Yifei; Huang, Xiaojing; Han, Dandan; Duan, Liguang; Wang, Qinchao; Zhang, Zihuan; Liu, Mingyue; Du, Linliu; Wang, Jianxin Journal: CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT. 2026; Vol. 15, Issue 6, pp. -. DOI: 10.1002/cpdd.70069 Population Pharmacokinetic-Based Meropenem Dosing in Critically and Non-Critically Ill Patients with Mixed Gram-Negative Bacterial Infections Author: Shi, Shuo; Cui, Jie; Liu, Guangqing; Gao, Jin; Bai, Wanjun Journal: CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT. 2026; Vol. 15, Issue 6, pp. -. DOI: 10.1002/cpdd.70067 Pharmacokinetics and Tolerability of Entacapone, Levodopa, and Carbidopa Tablets in Healthy Chinese Subjects: A Randomized, Open-Label, Four-Period Crossover Study Under Fasting and Fed Conditions Author: Wang, Jingyan; Xu, Yuan; Tao, Ye; Ma, Xuewei; Zou, Yang; Yang, Zhen; Lan, Yi Journal: CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT. 2026; Vol. 15, Issue 6, pp. -. DOI: 10.1002/cpdd.70071 Comparative Pharmacokinetics of Two Extended-Release Tablet Formulations of Upadacitinib: Bioequivalence Assessment Author: Sun, Biao; Zhao, Li; Gan, Fangliang; Zhan, Qiong Journal: CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT. 2026; Vol. 15, Issue 6, pp. -. DOI: 10.1002/cpdd.70073 | |||||||||||||||||||||
| 期刊语言要求 | Language Manuscripts must be written in American English and be grammatically and linguistically correct. Authors should seek assistance with style, grammar and vocabulary if necessary. Your manuscript may also be sent back to you for revision if the quality of English language is poor. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Clinical Pharmacology in Drug Development的语言要求，还能让Clinical Pharmacology in Drug Development编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Clinical Pharmacology in Drug Development编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||
| 通讯方式 | 111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774 | |||||||||||||||||||||
| 出版商 | Wiley-Blackwell | |||||||||||||||||||||
| 涉及的研究方向 | PHARMACOLOGY & PHARMACY- | |||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | ||||||||||||||||||||||
| 出版年份 | 0 | |||||||||||||||||||||
| 年文章数 | 117点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 47.75% | |||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 99.15% | |||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||
  | ||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2160-7648%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验： | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Clinical Pharmacology in Drug Development顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||
| 期刊常用信息链接 | ||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Effect of High-Fat Meal on the Pharmacokinetics and Safety of Lansoprazole Enteric-Coated Capsules in Healthy Chinese Subjects Author: Wang, Yifei; Huang, Xiaojing; Han, Dandan; Duan, Liguang; Wang, Qinchao; Zhang, Zihuan; Liu, Mingyue; Du, Linliu; Wang, Jianxin Journal: CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT. 2026; Vol. 15, Issue 6, pp. -. DOI: 10.1002/cpdd.70069 PubMed DOI |
| 2. | Population Pharmacokinetic-Based Meropenem Dosing in Critically and Non-Critically Ill Patients with Mixed Gram-Negative Bacterial Infections Author: Shi, Shuo; Cui, Jie; Liu, Guangqing; Gao, Jin; Bai, Wanjun Journal: CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT. 2026; Vol. 15, Issue 6, pp. -. DOI: 10.1002/cpdd.70067 PubMed DOI |
| 3. | Pharmacokinetics and Tolerability of Entacapone, Levodopa, and Carbidopa Tablets in Healthy Chinese Subjects: A Randomized, Open-Label, Four-Period Crossover Study Under Fasting and Fed Conditions Author: Wang, Jingyan; Xu, Yuan; Tao, Ye; Ma, Xuewei; Zou, Yang; Yang, Zhen; Lan, Yi Journal: CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT. 2026; Vol. 15, Issue 6, pp. -. DOI: 10.1002/cpdd.70071 PubMed DOI |
| 4. | Comparative Pharmacokinetics of Two Extended-Release Tablet Formulations of Upadacitinib: Bioequivalence Assessment Author: Sun, Biao; Zhao, Li; Gan, Fangliang; Zhan, Qiong Journal: CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT. 2026; Vol. 15, Issue 6, pp. -. DOI: 10.1002/cpdd.70073 PubMed DOI |
| 5. | Comparative Pharmacokinetics and Bioequivalence Assessment of Metformin/Pioglitazone Tablet in Fasting and Fed Conditions: A Randomized Study in Healthy Chinese Subjects Author: Li, Hongcheng; Li, Mengke; Liu, Bin; Wei, Zijie; Chen, Lulu; Li, Chao; Fang, Qing; Wang, Xintong; Zhou, Ling; Ouyang, Dongsheng; Li, Xiaohui Journal: CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT. 2026; Vol. 15, Issue 5, pp. -. DOI: 10.1002/cpdd.70063 PubMed DOI |
| 6. | Bioequivalence and Safety Assessment of Brivaracetam Dry Syrup Compared With Tablets in Healthy Japanese Participants: Results From Two Randomized Single- and Multiple-Dose Trials Author: Hayakawa, Yoshinobu; Yoshinaka, Ryoji; Sano, Tomonobu; Krauwinkel, Walter; Soma, Tadaharu; Sasamoto, Hiroshi; Elshoff, Jan-Peer; Bass, Almasa; Chen, Ying; Kurihara, Nozomi; Murakami, Harumi Journal: CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT. 2026; Vol. 15, Issue 4, pp. -. DOI: 10.1002/cpdd.70057 PubMed DOI |
| 7. | Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Voriconazole Tablets in Healthy Chinese Volunteers Author: Luo, Pan; Lei, Yongfang; Liu, Chang; Du, Juan; Deng, Xiangxiao; Yu, Hengyi; Qi, Xingxing; He, Zheng; Zhang, Dongling; Zuo, Qin; Fang, Yinian; Liu, Dong; Chen, Qian; Ren, Xiuhua Journal: CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT. 2026; Vol. 15, Issue 4, pp. -. DOI: 10.1002/cpdd.70058 PubMed DOI |
| 8. | Effect of High-Fat Diet on Pharmacokinetics and Incidence of Adverse Reactions of Tacrolimus in Healthy Chinese Participants Author: Zhu, Xiufang; Shi, Lingxue; Yang, Lan; Zhang, Nana; Wu, Yujie; Yin, Peihua; Wang, Jianxin; Zhou, Chunhua Journal: CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.1002/cpdd.70049 PubMed DOI |
| 9. | Pharmacokinetics and Bioequivalence of 2 Deutetrabenazine Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions Author: Xu, Dayong; Wang, Pengkai; Li, Yuan; Zhang, Ping; Wei, Liying; Xiong, Xiaolian; Li, Xin Journal: CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.1002/cpdd.70054 PubMed DOI |
| 10. | A Randomized, Double-Blind, Two-Treatment, Two-Period, Crossover Study Investigating the Systemic Bioavailability of a Novel Cocrystal Ubiquinol Formulation Compared with a Ubiquinone Formulation in Healthy Adults Author: Mei, Xuefeng; Zhu, Bingqing; Soni, Kshitij; Kasaraneni, Kishore; Panchal, Nirav Journal: CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.1002/cpdd.70042 PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共8条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
